Faster global financial news!
Analysis shows Johnson & Johnson's latest 13F filing reveals holdings in 15 biotech stocks, with Protagonist Therapeutics being the largest investment, whose stock price has surged 65% year-to-date.
According to Yahoo Finance analysis, Johnson & Johnson's latest 13F filing (as of June 30, 2026) disclosed its holdings of 15 stocks in the biotechnology and medical technology sectors. The analysis indicates that Johnson & Johnson's largest investment is in Protagonist Therapeutics, amounting to approximately $300 million. Protagonist Therapeutics had one product launched in the US in March 2026, and the FDA approval decision for another product, rusfertide, is expected in August 2026. As of August 28, 2026, Protagonist Therapeutics' stock price has risen by 65% year-to-date.
Source：Yahoo财经 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
Previous: Analysis indicates NVIDIA is poised to achieve $1 trillion in revenue by fiscal year 2029, but Amazon may reach it sooner.
|
Next: Xingyu Co., Ltd. is embroiled in labor disputes during a critical period for its Hong Kong IPO, reportedly terminating contracts with 107 fresh graduates and exceeding limits on labor dispatch.
24H Trending
-
1
Billionaire hedge fund manager Daniel Loeb's Third Point made significant investments totaling over $350 million in Bitcoin mining companies transitioning to AI and Block during Q2 2026.
-
2
Energy Transfer (ET) has become a major natural gas supplier to AI data centers, securing deals with Oracle, Nexus, Crusoe, and Entergy to meet surging power demand.
-
3
Bernstein Analyst Gautam Chhugani Predicts Bitcoin Could Hit $1 Million by 2033, Citing US Dollar Debasement as Key Driver
-
4
XRP (XRP) 2023 Market Performance Review and Analysis of Potential to Break $10 in the Future
-
5
Saudis Said to Seek About $8B in Loans as War Strains Finances
-
6
South Korea Rejects U.S. Congressional Allegations of Discrimination Against Coupang, Amidst Strained U.S.-Korea Relations and Pressure from Potential U.S. Tariffs
-
7
Bybit Lists OKTAUSDT TradFi Perpetual Contract, Offering Up to 25x Leverage
-
8
Bybit Lists EWZUSDT TradFi Perpetual Contract with Up to 25x Leverage
-
9
BST (Blocksquare Token) Analysis: Real Estate Tokenization Vision and Market Status
-
10
What is BURN Coin? An Analysis of the Token and its Trading Status
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
